25-08-2026 23:15 via medpagetoday.com

'Practice-Changing' Data Expand Zanidatamab's Approval to Gastroesophageal Cancer

(MedPage Today) -- The FDA approved zanidatamab (Ziihera) plus tislelizumab (Tevimbra) and chemotherapy as first-line treatment for unresectable/metastatic HER2-positive gastroesophageal cancer.
The approval stipulates use in adults with unresectable...
Read more »

Medical Industry news



First Drug OK'd for Warm Autoimmune Hemolytic Anemia
More NFL Players Have CTE Than Previously Thought, Study Suggests
Trump Cuts Mask True Extent of Cyclospora Outbreaks
FDA Authorizes First Wearable Dual Glucose-Ketone Sensor
Monoclonal for Dengue Shows Promise in Hospitalized Cases
'Gray Market' Retatrutide Study; Menopause and the Brain; Drug Allergy Warnings
Controversial Neurologist to Lead NIH Unit; Hunter Trial Halted; Dads and Valproate
Dementia Drug Helpful With Lupus Brain Fog
Trump Administration Takes Second Swing at Hefty Fees for Visa Applicants
AI-Flagged PH & Pericarditis; Lagging Cardiology Workforce; Multi-Day Heart Rhythms
Clearing Out the Clutter, in Our Drawers and in Healthcare
U.S. Measles Deaths Reported
Florida, Hard-Hit by ACA Drop-Off, Feels the Squeeze of Rising Healthcare Costs
FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care
Desktop versie